Skip to main navigation

Overview
Corporate
News & Events
Stock Information
Financial Information
- SEC Filings
- Quarterly Results
IR Resources

News & Events

News Releases

News Releases

All
2022
2021
2020
2019

2021.02.01

Exelixis and Adagene Enter into Collaboration and License Agreement to Develop Novel Masked Antibody-Drug Conjugate Therapies with Improved Safety and Efficacy Profiles

2021.01.12

Adagene Announces Milestone of CAR-T Collaboration with the National Heart, Lung, and Blood Institute at the National Institutes of Health

2020.12.02

Adagene Announces Expansion of Leadership Team to Support Strategic Growth

2020.06.10

Adagene Announces Strategic Collaboration Agreement with Tanabe Research Laboratories

2020.05.29

Adagene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Next page
Last page

Displaying 36 - 40 of 46

Shareholder Tools

© 2022 Adagene Inc.

Footer Bottom

Home
Privacy
Terms of Use
Contact
Site Credits
LinkedIn